[Federal Register Volume 68, Number 169 (Tuesday, September 2, 2003)]
[Notices]
[Page 52226]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-22322]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration

    By Notice dated May 2, 2003 and published in the Federal Register 
on May 29, 2003, (68 FR 32089), Roche Diagnostics Corporation, 9115 
Hague Road, Indianapolis, Indiana 46250, made application by renewal to 
the Drug Enforcement Administration (DEA) to be registered as an 
importer of Schedules I & II, for the basic classes of controlled 
substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Lysergic Acid Diethylamide (7315)..........  I
Tetrahydrocannabinols (7370)...............  I
Alphamethadol (9605).......................  I
Phencyclidine (7471).......................  II
Benzoylecogonine (9180)....................  II
Methadone (9250)...........................  II
Morphine (9300)............................  II
------------------------------------------------------------------------

    The firm plans to import the listed controlled substances to 
manufacture diagnostic products for distribution to its customers.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, Section 823(a) and 
determined that the registration of Roche Diagnostics Corporation to 
import the listed controlled substances is consistent with the public 
interest and with United States obligations under international 
treaties, conventions, or protocols in effect on May 1, 1971, at this 
time. DEA has investigated Roche Diagnostics Corporation on a regular 
basis to ensure that the company's continued registration is consistent 
with the public interest. This investigation included inspection and 
testing of the company's physical security systems, verification of the 
company's compliance with state and local laws, and a review of the 
company's background and history. Therefore, pursuant to Section 
1008(a) of the Controlled Substances Import and Export Act and in 
accordance with Title 21, Code of Federal Regulations, Section 1301.34, 
the above firm is granted registration as an importer of the basic 
classes of controlled substances listed above.

    Dated: August 19, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-22322 Filed 8-29-03; 8:45 am]
BILLING CODE 4410-09-M